CIP
PFE icon

Chartwell Investment Partners’s Pfizer PFE Stock Holding History

Chartwell Investment Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-9,411
Closed -$350K – 418
2019
Q4 		$350K Sell
9,411
-528,771
-98% -$18.8M 0.01% 393
2019
Q3 		$18.3M Buy
538,182
+1,653
+0.3% +$60.1K 0.61% 27
2019
Q2 		$22.1M Buy
536,529
+46,012
+9% +$1.83M 0.72% 15
2019
Q1 		$19.8M Buy
490,517
+3,548
+0.7% +$142K 0.64% 21
2018
Q4 		$20.2M Sell
486,969
-43,531
-8% -$1.81M 0.71% 21
2018
Q3 		$22.2M Sell
530,500
-51,194
-9% -$1.97M 0.65% 20
2018
Q2 		$20M Sell
581,694
-2,665
-0.5% -$91.1K 0.6% 29
2018
Q1 		$19.7M Buy
584,359
+12,364
+2% +$425K 0.67% 26
2017
Q4 		$19.7M Sell
571,995
-56,521
-9% -$1.93M 0.67% 23
2017
Q3 		$21.3M Buy
628,516
+17,228
+3% +$554K 0.73% 18
2017
Q2 		$19.5M Sell
611,288
-27,626
-4% -$871K 0.73% 23
2017
Q1 		$20.7M Buy
638,914
+92,746
+17% +$2.92M 0.76% 25
2016
Q4 		$16.8M Sell
546,168
-165,594
-23% -$5.06M 0.57% 49
2016
Q3 		$22.9M Buy
711,762
+24,831
+4% +$830K 0.41% 57
2016
Q2 		$22.9M Sell
686,931
-26,028
-4% -$831K 0.41% 53
2016
Q1 		$20M Buy
712,959
+22,197
+3% +$634K 0.38% 63
2015
Q4 		$21.2M Sell
690,762
-10,396
-1% -$327K 0.43% 59
2015
Q3 		$20.9M Sell
701,158
-17,798
-2% -$571K 0.45% 65
2015
Q2 		$22.9M Sell
718,956
-12,453
-2% -$406K 0.45% 64
2015
Q1 		$24.1M Buy
731,409
+41,591
+6% +$1.32M 0.47% 65
2014
Q4 		$20.4M Buy
689,818
+35,336
+5% +$1.01M 0.43% 68
2014
Q3 		$18.4M Sell
654,482
-1,940
-0.3% -$54.4K 0.41% 70
2014
Q2 		$18.5M Buy
656,422
+28,062
+4% +$800K 0.39% 100
2014
Q1 		$19.1M Buy
628,360
+2,624
+0.4% +$78.2K 0.39% 101
2013
Q4 		$18.2M Sell
625,736
-157,483
-20% -$4.58M 0.37% 97
2013
Q3 		$21.3M Buy
783,219
+74,217
+10% +$2.02M 0.48% 58
2013
Q2 		$18.8M Buy
+709,002
New +$19.6M 0.48% 60

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Chartwell Investment Partners's PFE Position: Q1 2020 in Review

Chartwell Investment Partners sold out of Pfizer (PFE) in Q1 2020, closing a stake of 9,411 shares — an estimated $350K sold.

Chartwell Investment Partners first reported a position in PFE in Q2 2013 and held it in 27 quarters. The position peaked at $24.1M in Q1 2015. 2,437 funds tracked by Wall St. Rank hold PFE as of Q1 2020.

  • Chartwell Investment Partners reported no remaining Pfizer position as of Q1 2020 after selling out during the quarter.
  • Chartwell Investment Partners sold 9,411 Pfizer shares in Q1 2020, an estimated $350K.
  • Chartwell Investment Partners first reported a position in Pfizer in Q2 2013 and held it in 27 quarters.
  • Chartwell Investment Partners's Pfizer position peaked at $24.1M in Q1 2015.
  • 2,437 funds tracked by Wall St. Rank held Pfizer as of Q1 2020.

Based on Chartwell Investment Partners's 13F filing for Q1 2020, filed 30 Apr 2020.